164 related articles for article (PubMed ID: 4114691)
21. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
[No Abstract] [Full Text] [Related]
22. Contact dermatitis to antituberculosis drugs.
Holdiness MR
Contact Dermatitis; 1986 Nov; 15(5):282-8. PubMed ID: 3545669
[TBL] [Abstract][Full Text] [Related]
23. Adverse effects of antituberculosis drugs.
Girling DJ
Drugs; 1982; 23(1-2):56-74. PubMed ID: 6459920
[No Abstract] [Full Text] [Related]
24. [NEW COMBINATIONS OF ANTITUBERCULAR AGENTS IN THE TREATMENT OF RENAL TUBERCULOSIS].
SZENDROEI Z; CSERNUS A
Magy Seb; 1964 Apr; 17():124-7. PubMed ID: 14152677
[No Abstract] [Full Text] [Related]
25. [Rheumatic diseases caused by antitubercular drugs].
Anastasatu C; Stoia I; Kaufman S; Ghenoiu O; Iancovici O
Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan; 136(1):51-63. PubMed ID: 4538033
[No Abstract] [Full Text] [Related]
26. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
NOVAK M; JANCIK E
Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
[No Abstract] [Full Text] [Related]
27. CHEMOTHERAPY OF TUBERCULOSIS.
HORNE NW
Biochem Clin; 1964; 4():207-15. PubMed ID: 14268921
[No Abstract] [Full Text] [Related]
28. RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
CORPE RF; BLALOCK FA; GROSS JH; GOLDHAMMER EJ
Am Rev Respir Dis; 1964 Dec; 90():957-60. PubMed ID: 14233802
[No Abstract] [Full Text] [Related]
29. Multiple-drug reactions in tuberculosis--an illustrative case.
Govindaraj M
Tubercle; 1968 Dec; 49(4):416-8. PubMed ID: 4237763
[No Abstract] [Full Text] [Related]
30. Antituberculous drugs.
Warkany J
Teratology; 1979 Aug; 20(1):133-7. PubMed ID: 92814
[No Abstract] [Full Text] [Related]
31. RECENT ADVANCES IN TREATMENT OF ORGAN TUBERCULOSIS.
PFUETZE KH; PYLE MM
JAMA; 1964 Mar; 187():805-10. PubMed ID: 14094316
[No Abstract] [Full Text] [Related]
32. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
SCHWARTZ WS
Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
[No Abstract] [Full Text] [Related]
33. PULMONARY TUBERCULOSIS.
CHAVES AD
Mod Treat; 1964 Mar; 1():330-59. PubMed ID: 14159591
[No Abstract] [Full Text] [Related]
34. Thrombocytopenia and sideroblastic anemia with pyrazinoic acid amide (pyrazinamide) therapy.
MacCurdy RK; Simon ER
Chest; 1970 Apr; 57(4):378-81. PubMed ID: 5434719
[No Abstract] [Full Text] [Related]
35. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
KASS I
Tubercle; 1965 Jun; 46():166-77. PubMed ID: 14327964
[No Abstract] [Full Text] [Related]
36. [Advances and principles in tuberculostatic therapy].
Bethge H
Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
[No Abstract] [Full Text] [Related]
37. [INTOLERANCE AND TOXICITY OF SUBSTITUTE ANTIBACTERIAL DRUGS].
BEK E
Gruzlica (1926); 1963 Jun; 31():645-51. PubMed ID: 14119445
[No Abstract] [Full Text] [Related]
38. [The pseudorheumatism of antitubercular chemotherapy. Contribution to the study of the etiopathogenesis of neurotrophic rheumatism].
Marche J; Chatard P
Rev Rhum Mal Osteoartic; 1967; 34(1):16-33. PubMed ID: 4169554
[No Abstract] [Full Text] [Related]
39. [ETHIONAMIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
ZIERSKI M
G Ital Chemioter; 1963; 10():110-7. PubMed ID: 14074246
[No Abstract] [Full Text] [Related]
40. Treatment of tuberculosis.
Bates JH
Adv Intern Med; 1975; 20():1-21. PubMed ID: 46687
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
